To this end, we randomly selected 117 patients who were newly diagnosed with locally advanced NPC and treated with radiotherapy plus cisplatin-based chemotherapy (at least 2 cycles) (Supplementary Table 1), and examined BST2 expression by IHC in biopsy tumor specimens. This evidence concerns the gene BST2 and nasopharyngeal carcinoma.